STAT News, March 1, 2021: The FDA is approving more new cancer drugs than ever before, after FDA’s drug chief Janet Woodcock loosened FDA standards. Now cancer doctors are Woodcock’s most vocal backers in her campaign to be FDA Commissioner. But critics say too many approved cancer drugs aren’t proven to help patients live longer.
Read More »Tag: cancer
FDA blasts Merck’s Keytruda data for new breast cancer indication
Stat News, February 5, 2021. The cancer drug Keytruda is a medical and financial juggernaut, but it may not win FDA approval for early-stage triple negative breast cancer. FDA medical reviewers agreed there is a need for new treatments, but Keytruda did not impress them with its small benefit of “questionable clinical meaningfulness” and serious safety issues. NCHR’s Dr. Zuckerman said “This is one of the most negative reviews I’ve ever seen.”
Read More »Comparison of Acupuncture and Therapy as Treatments for Cancer Survivors with Insomnia
Both acupuncture and CBT-I helped reduce insomnia symptoms in cancer survivors. The researchers concluded that CBT-I should be used as the first line of treatment for cancer-related insomnia, but acupuncture is a good alternative.
Read More »How the Coronavirus Pandemic May Affect Cancer Clinical Trials
Cancer Therapy Advisor, August 18, 2020. The dangers of Covid-19, especially to cancer patients, are upending access to clinical trials for cancer treatments.
Read More »We can’t ever go to the doctor with our guard down’: Why Black women are 40% more likely to die of breast cancer
Fortune Magazine: June 30, 2020 Black Americans are dying from the COVID-19 pandemic at a disproportionately high rate, and are also much more likely to die from many other health problems. Black women are less likely to develop breast cancer but 40% more likely to die from it than White women. The reasons behind this awful disparity are wide-ranging, and include systemic problems both within healthcare and far beyond it.
Read More »